[ Price : $8.95]
FDA approves a Cycle Pharmaceuticals NDA for Harliku (nitisinone) tablets for reducing urine homogentisic acid in adult patients w...[ Price : $8.95]
Two SheppardMullin attorneys say it remains to be seen whether a recent FDA Warning Letter to DRG Instruments about selling resear...[ Price : $8.95]
FDA says it is reviewing all clinical trials that rely on a Biden administration exemption that allowed sensitive biological mater...[ Price : $8.95]
FDA places CBER Office of Therapeutic Products director Nicole Verdun and her deputy Rachael Anatol on administrative leave in the...[ Price : $8.95]
The FDA Office of Regulatory and Emerging Science publishes a report describing agency efforts to research cybersecurity and advan...[ Price : $8.95]
Bavarian Nordic enters into an agreement to sell for $160 million a priority review voucher that was awarded for gaining approval ...[ Price : $8.95]
A Texas federal judge rules FDA acted properly in removing Novo Nordisks Ozempic and Wegovy from its drug shortage list.[ Price : $8.95]
Former FDA commissioner Scott Gottlieb expects FDA will reevaluate Sareptas approval of Duchenne muscular dystrophy gene therapy E...